Saratov JOURNAL of Medical and Scientific Research

Comparative analysis of the application of the above- threshold laser coagulation and micropulse laser exposure in central serous chorioretinopathy

Year: 2019, volume 15 Issue: №2 Pages: 532-536
Heading: Ophtalmology Article type: Original article
Authors: Popova N.V., Fabrikantov O.L., Goydin A.P.
Organization: S. Fedorov Eye Microsurgery Federal State Institution, Tambov State University n. a. G.R. Derzhavin

Purpose: to determine the efectiveness of above-threshold (focal) laser coagulation and micropulse laser exposure (MPLV) in patients with central serous chorioretinopathy (CCA). Material and Methods. 91 people with a diagnosis of CCA were examined. The median age was 35.2 years. Patients of the 1st group (n=19) was performed MPLV a wavelength of 810 nm; group 2 (n=31) — about threshold photocoagulation with the wavelength of 810 nm. Control group — 50 people with a natural course of the process. Results. After 1 month after treatment in group 1, visual acuity increased from 0.5±0.08 to 0.8±0.03. According to optical coherence tomography (OCT), the neuroepithelial detachment decreased from 446 to 341.3 MK. With the chronic course of the process after laser treatment, recurrence of the disease was revealed, which required an additional session of MPLV. In group 2, after 1 month, visual acuity increased from 0.6±0.20 to 0.8±0.03, neuroepithelial detachment decreased from 365 to 269 MK. Relapse of the disease in chronic form required an additional session of MPLV. After 3 months, both groups showed complete adhesion of the neurosensory retina and increased visual acuity to 0.9±1.0. Conclusion. Laser coagulation (above- threshold laser coagulation, micropulse laser exposure) is minimally invasive and highly efective in the treatment of central serous chorioretinopathy. The choice of laser treatment method depends on the

1 Popova NV, Goydin AP. Application of micropulse laser infuence in central serous chorioretinopathy. Practical medicine 2016; 98 (6): 137–41
2 Shchegoleva IV, Budzinskaya MV. Central serous chorioretinopathy: etiology and pathogenesis. Russia annals of ophthalmology 2010; (3): 55–8
3 Carvalho-Recchia C, Yannuzzi L, Negrao S, et al. Corticosteroids and central serous chorioretinopathy. Ophthalmology 2002; 109: 1834–7
4 Gatsu MV, Iskenderova NG. The efect of steroid therapy on the development and course of central serous chorioretinopathy. In: Theses of the reports of IV All-Russian round table talk: Macula-2010. Rostov-na-Donu, 2010; p. 427–9
5 Balashevich LI, Kasimov EM, Iskanderova NG, et al. Modern conceptions about etiology and pathogenesis of central serous choriopathy. Ophthalmosurgery 2007; (2): 63–7
6 Kitaya N, Nagaoka T, Hikichi T, et al. Features of abnormal choroidal circulation in central serous chorioretinopathy. Br I Ophthalmol 2003; 87: 709–12
7 Sekiryu T, Iida T, Maruko I, et al. Infared Fundus Autofuorescence and Cenral Serous Chorioretinopathy. Investigative Ophthalmology & Visual Science 2010; 51 (10): 4956–62
8 Iida T, Kishi S, Hagimura N, et al. Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. Retina 1999; 19: 508–12
9 Kamppeter B, Jonas JB. Central serous chorioretinopathy imaged by optical coherence tomography. Arch Ophthalmol 2003; 121: 742–3
10 Wang M, Sander B. Retinal atrophy in central serous chorioretinopathy. Am J Ophtalmol 2002; 133: 787–93
11 Ross A, Ross AH. Quersh Mohamed Review and update of central serous chorioretinopathy. Curr Opin Ophthalmol 2011; 22: 166–73
12 Marmor MF. New hypotheses on the pathogenesis and treatment of serous retinal detachment. Graefes Arch Clin Exp Ophthalmol 1988; 226: 548–52
13 Creenstein VC, Chen H, Hood DC, et al. Retinal functions in diabetic macular edema after focal laser photocoagulation. Invest Ophthalmol Vis Sci 2000; 41 (11): 3655–64
14 Rufege BK, Wallow IH, Poulsen GL. Sub-pigment epithelial membranes after photocoagulation diabetic macular edema. Arch Ophthalmol 1993; 111: 608–13
15 Machekhin VA, Goydin AP, Yablokova NV, et al. Treatment of central serous choriopathy. In: Theses of the reports of I All-Russian round table talk: Macula-2004. Rostov-na-Donu, 2004; p. 224–8
16 Eliseeva EG, Pereverzina OK. Argon laser in treating central serous chorioretinopathies. In: Laser methods of treatment in ophthalmology. Moscow, 1984; p. 114–21
17 Gupta B, Elagouz M, Mc Hugh D, et al. Micropulse diode laser photocoagulation for central serous chorioretinopathy. Clin Experiment Ophthalmol 2009; 37 (8): 801–5
18 Lanzetta P, Furlan F, Morgante L, Veritti D. Nonvisible subthreshold micropulse diod laser (810 nm) treatment of central serous chorioretinopathy: A pilot study. Eur I Ophthalmol 2008; 18 (6): 934–40
19 Koss MI, Beger I, Koch FH. Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy. Eye (Lond) 2012; 26 (2): 307–14
20 Balashevich LI, Gatsu MV, Iskenderova NG. The efcacy of diode subthreshold laser coagulation in treating diferent forms of central serous retinopathy. In: Theses of the reports of IV All-Russian round table talk: Macula-2010. Rostov-na-Donu, 2010; p. 414–6.

2019_02-1_532-536.pdf334.76 KB

No votes yet